REMEDISC
Live / Applied — Third extension granted (statement of use) (as of 02 Feb 2026)
What this means for you
Not registered yet, but its 23 Feb 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97809425
- Mark type
- Stylized text
- Filed
- 23 Feb 2023
- Published for opposition
- 09 Jul 2024
- Attorney of record
- Tram Anh Nguyen
Goods and services
- Class 005 — Pharmaceuticals: Biomedical compounds, namely, amino acids for medical purposes administered for medical therapies; amino acids for medical purposes administered by injection for treatment of spinal diseases or disorders; 7-amino acid peptide chain, namely, amino acids for medical purposes administered by intradiscal injection for the treatment of lumbar degenerative disc disease.
Owner
- Spine Biopharma, LLC, New York, NY, US
- Spine Biopharma, LLC, New York, NY, US
Prosecution history
- 03 Feb 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 02 Feb 2026 — SOU EXTENSION 3 GRANTED
- 02 Feb 2026 — SOU EXTENSION 3 FILED
- 02 Feb 2026 — SOU TEAS EXTENSION RECEIVED
- 15 Sept 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 04 Jun 2025 — SOU EXTENSION 2 GRANTED
- 04 Jun 2025 — SOU EXTENSION 2 FILED
- 04 Jun 2025 — SOU TEAS EXTENSION RECEIVED
- 02 Mar 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 01 Mar 2025 — SOU EXTENSION 1 GRANTED
- 28 Feb 2025 — SOU EXTENSION 1 FILED
- 28 Feb 2025 — SOU TEAS EXTENSION RECEIVED
- 06 Dec 2024 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 06 Dec 2024 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 06 Dec 2024 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED